openPR Logo
Press release

Hemostasis Market Estimated to Flourish by 2024

03-09-2018 11:21 AM CET | Health & Medicine

Press release from: Transparency Market Research

Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the market for hemostasis products has gained a prominent position in the field of medicine and healthcare.

This report on the global Hemostasis Market is an attempt to give the reader in-depth insights regarding the present state of technological advancements, available products in the global market, highly anticipated products that are undergoing clinical trials, and future scope of development. The report includes a snapshot of the market considering detailed market data pertaining to key segments and sub segments. An exhaustive account of the present market value or prominence of these segments and sub segments for global as well as key regional markets is also included in the report.

The research includes data that has been collated from primary and secondary research efforts. Market size in terms of revenue (US$ mn/bn) and volume (Kilo Tons) are includes for all the segments for the period between 2016 and 2024, with 2015 considered the base year for research. Past data according to popular trends has also been included in the report. A thorough account of the key factors such as drivers, restraints, challenges, past and present trends, key regulations, rules, and opportunities in the market is also included in the report.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2401

Global Hemostasis Market: Drivers and Restraints

The rising global prevalence of Hemophilia A and B, the most common inherited bleeding disorders, a significant surge in a variety of surgeries and trauma patients, and the rising use of recombinant products are collectively driving the global hemostasis market. The rapid rate of introduction of cost effective and biodegradable products in the global market is also aiding the growth of the market. Growth across cost-sensitive emerging markets is being essentially a product of the easy availability of cost-effective products. However, the vast saturation in the global hemostasis market and high cost structures of advanced hemostasis product varieties are hampering the growth of the market.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2401

Global Hemostasis Market: Segmentation

The report segments the global hemostasis products market on the basis of criteria such as product type and geography. On the basis of product type, the market is segmented into: infusible hemostats, topical hemostats, and advanced hemostats and sealants.

The segment of topical hemostats is further segmented into oxidized regenerated cellulose, collagen, and gelatin. Topical hemostats find significant usage in surgery settings and are the most preferred hemostats as compared to other varieties owing to their ease of use, cost effectiveness, biodegradable nature, and efficiency. Of the key types of topical hemostats available in the market, collagen in the most prominently used as it starts acting immediately by beginning to clot blood by natural pathways.

The segment of infusible hemostats, comprising products such as prothrombin complex, fresh frozen plasma, platelet concentrates gathered from donor blood, and FVIII derived from blood, finds usage mostly only under specific conditions and severe hemorrhages. In comparison, the segment of advanced hemostats, consisting products that have been marketed in recent years, are finding extensive usage owing to their high efficiency rates. Many advanced hemostats and sealants are under research and clinical trials.

Companies Mentioned in Report

The report includes a detailed overview of the business profiles and recent developments for some of the key companies operating in the global hemostasis market. Companies discussed in the report include Abbott Laboratories, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Chrono-Log Corporation, and Trinity Biotech plc.

View Report -

https://www.transparencymarketresearch.com/hemostasis-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemostasis Market Estimated to Flourish by 2024 here

News-ID: 971875 • Views: 239

More Releases from Transparency Market Research

Ion Exchange Resins Market to reach US$ 3,827.6 Mn by 2026
Albany, NY - According to a Transparency Market Research Report, the competition in the global ion exchange resins market is marked by fierce competition. Most players are expanding their product line with growing application for ion exchange resins. On the other hand, with some section of applications in scaling up, companies in the ion exchange market are working on developing techniques for large scale production of the product. Furthermore, the global
Recycled Metal Market to Reach US$ 979 Billion by 2026
Albany, NY - The recycled metal market was valued at US$ 713.44 Bn in 2017 is anticipated to expand at a CAGR of 3.5% during the forecast period, according to a new report published by Transparency Market Research (TMR) titled ‘Recycled Metal Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026’. Expansion in the recycled metal market is primarily driven by the increase in awareness about
Powder Metallurgy Market to expand at a CAGR of 6.8% by 2026
Albany, NY - Transparency Market Research (TMR) witnesses that the global powder metallurgy market has a consolidative vendor landscape owing to the dominance of few players. The key players operating in the global powder metallurgy market are GKN Hoeganaes, Sumitomo Electric Company Ltd, H.C. Starck, Sandvik AB, and Hitachi Chemical Company Ltd. Top three companies such as Sumitomo Electric Company Ltd, Fine Sinter Company Ltd, and GKN Hoeganaes collectively accounted for 35%
Wood Activated Carbon Market worth US$ 1,571.84 Mn by 2026
Albany, NY - According to a new report titled ‘Wood Activated Carbon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,’ published by Transparency Market Research (TMR), the global wood activated carbon market was valued at US$ 785.80 Mn in 2017 and is anticipated to expand at a CAGR of 8.1% from 2018 to 2026. The global wood activated carbon market is driven by stringent regulations on mercury emission from

All 5 Releases


More Releases for Hemostasis

Hemostasis Global Clinical Trials Review H2 2017
ReportsWeb.com published “Hemostasis Global Clinical Trials Review H2 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's clinical trial report, "Hemostasis Global Clinical Trials Review, H2, 2017" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an
2017 Hemostasis Devices Market Embraces Advancements
This report studies Hemostasis Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Olympus RevMedx Z-Medica Argon Medical Devices C.R. Bard TZ Medical ... Ask for sample copy @ https://www.researchtrades.com/request-sample/1216946 By types, the market can
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Diagnostics Market: Global Markets & Advanced Technologies
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Products Market Analysis – 2024
The top four vendors operating in the global hemostasis products market, including Ethicon, Pfizer Inc., Baxter International, Inc., and CR Bard, Inc., accounted for a share of nearly 41% in the market in 2015, states Transparency Market Research in a recent report. In the seemingly fragmented market, where small- and medium-scale vendors accounted for over 59% in the overall market in the 2015, a large number of these players provided
Hemostasis Products Market: Global Markets & Advanced Technologies
This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study